Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$3.27 - $8.76 $5,232 - $14,016
-1,600 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$7.56 - $14.3 $756 - $1,430
100 Added 6.67%
1,600 $13,000
Q4 2021

Feb 03, 2022

SELL
$12.24 - $21.25 $24,480 - $42,500
-2,000 Reduced 57.14%
1,500 $17,000
Q3 2021

Oct 18, 2021

BUY
$16.69 - $26.05 $58,415 - $91,175
3,500 New
3,500 $67,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $240M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.